Takayuki Kondo

4PUBLICATIONS
35CO-AUTHORS
Medical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 06, 2026
Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trial.

Yunosuke Kawaguchi, Keita Terui, Takashi Fumita

|Apr 07, 2024
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

Kisako Fujiwara, Takayuki Kondo, Kentaro Fujimoto

|Oct 05, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.

Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta

|Jan 27, 2022
Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.

Takayuki Kondo, Keisuke Koroki, Hiroaki Kanzaki

Pageof 1